On November 25, 2024, Steven Collis, Executive Chairman of Cencora Inc (COR, Financial), sold 50,000 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 321,912.665 shares of the company.
Cencora Inc is a global healthcare solutions company that provides pharmaceutical distribution and related services designed to improve patient outcomes. The company operates in various segments, including pharmaceutical distribution, specialty solutions, and consulting services.
Over the past year, Steven Collis has sold a total of 246,939 shares and has not purchased any shares. The insider transaction history for Cencora Inc shows that there have been 1 insider buy and 24 insider sells over the same timeframe.
On the day of the recent sale, shares of Cencora Inc were trading at $243.98, giving the stock a market cap of $48,698.088 million. The company's price-earnings ratio is 33.08, which is higher than the industry median of 20.21 and also higher than the company’s historical median price-earnings ratio.
With a price of $243.98 and a GuruFocus Value of $220.39, Cencora Inc has a price-to-GF-Value ratio of 1.11, indicating that the stock is modestly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
